Paper Details

  1. Home
  2. Paper Details

Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.

Author: CaballeroJoshua, OmidianHossein, ParkPauline

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review examined the efficacy and safety of venlafaxine and duloxetine for treating attention-deficit hyperactivity disorder (ADHD) in children and adolescents. While data is limited, the review found that venlafaxine may be a useful alternative treatment for ADHD when patients cannot tolerate or fail stimulants, tricyclic antidepressants, or bupropion. Duloxetine showed minimal efficacy in treating ADHD symptoms in the reviewed studies.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To review the current literature on the efficacy and safety of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder (ADHD) in the pediatric population. DATA SOURCES: A literature search from 1996 to August 2013 was conducted using MEDL...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1060028013506561

データ提供：米国国立医学図書館（NLM）

Serotonin Norepinephrine Reuptake Inhibitors for Pediatric ADHD

Treating [attention-deficit hyperactivity disorder (ADHD)] in children requires careful consideration. This study reviews the current evidence on the efficacy and safety of [serotonin norepinephrine reuptake inhibitors (SNRIs)] for pediatric ADHD. The researchers examined studies involving [venlafaxine and duloxetine] and concluded that [venlafaxine] showed potential as an alternative treatment option for children who don't respond well to traditional medications, while [duloxetine] exhibited limited efficacy.

Alternative Treatment Options for Pediatric ADHD

The study highlights the importance of exploring [alternative treatment options] for children with ADHD who do not respond adequately to [stimulants, tricyclic antidepressants, or bupropion]. While [venlafaxine] shows promise, further research is needed to confirm its efficacy and safety in this patient population. The limited evidence for duloxetine suggests that it may not be a suitable option for treating ADHD in children.

Navigating Childhood ADHD

Just as a camel adapts to the changing desert landscape, children with ADHD face unique challenges in navigating their development. This study offers valuable insights into the potential of SNRIs as alternative treatment options for pediatric ADHD. By understanding the nuances of these medications and carefully considering the available evidence, healthcare providers can make informed decisions about treatment strategies for children with ADHD.

Dr.Camel's Conclusion

Treating ADHD in children can be like guiding a camel through a shifting desert landscape. This study sheds light on the potential of SNRIs as alternative treatment options, but further research is needed to confirm their efficacy and safety. By carefully navigating the treatment landscape, healthcare professionals can help children with ADHD find the best path to a brighter future.

Date :
  1. Date Completed 2014-09-08
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

24259607

DOI: Digital Object Identifier

10.1177/1060028013506561

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.